SANGUI BIOTECH INTERNATIONAL INC: 10-Q filed 2012-11-15

Name: SANGUI BIOTECH INTERNATIONAL INC: 10-Q filed 2012-11-15
Creator: SANGUI BIOTECH INTERNATIONAL INC

What SANGUI BIOTECH INTERNATIONAL INC reported in its quarterly report filed 2012-11-15 (fiscal Q1 2013): 20 published measures, 38 facts as tagged in accession 0001104280-12-000019.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-11-15
Fiscal period: fiscal Q1 2013
Accession: 0001104280-12-000019 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SANGUI BIOTECH INTERNATIONAL INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-09-30	961,267	USD
At 2012-06-30	1,127,725	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-09-30	48,704	USD
At 2012-06-30	238,639	USD
At 2011-09-30	234,338	USD
At 2011-06-30	122,619	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-204,473	USD	92
2011-07-01 to 2011-09-30	-145,279	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,794	USD	92
2011-07-01 to 2011-09-30	1,181	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	258,362	USD	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-09-30	1,197	USD
At 2012-06-30	1,270	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-195,658	USD	92
2011-07-01 to 2011-09-30	-257,061	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-09-30	960,070	USD
At 2012-06-30	1,126,455	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-238	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-09-30	195,001	USD
At 2012-06-30	168,351	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	197,452	USD	92
2011-07-01 to 2011-09-30	256,783	USD	92

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2011-09-30	1,052	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	1,794	USD	92
2011-07-01 to 2011-09-30	-278	USD	92

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	8,444	USD	92
2011-07-01 to 2011-09-30	17,717	USD	92

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-195,896	USD	92
2011-07-01 to 2011-09-30	-254,854	USD	92

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-195,896	USD	92
2011-07-01 to 2011-09-30	-254,854	USD	92

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	-180,205	USD	92
2011-07-01 to 2011-09-30	-237,594	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	188,829	USD	92
2011-07-01 to 2011-09-30	238,679	USD	92

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2012-07-01 to 2012-09-30	106	USD	92
2011-07-01 to 2011-09-30	184	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2011-07-01 to 2011-09-30	231	USD	92

Inspect the source

Entity: SANGUI BIOTECH INTERNATIONAL INC / CIK 0001104280
Captured: 2026-09-22 19:39 UTC
SEC response SHA-256: 80929a3d07bdd3be99cfb5858d464edb9844d0e622d958ee5dce9515baeeed6f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001104280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))